PROJECT

Projects

Environmental & Social Review Summary

Project Number

51289

Company Name

GEORGIA HEALTHCARE GROUP JSC

Date ESRS Disclosed

Sep 17, 2025

Country

Georgia

Region

Europe

Last Updated Date

Sep 25, 2025

Environmental Category

B - Limited

Status

Active

Previous Events

Approved : Sep 9, 2025
Signed : Sep 11, 2025
Invested : Sep 17, 2025

Sector

Hospitals and Clinics

Industry

Health, Education and Life Sciences

Department

Regional Industry MAS LAC & EUR

Project Description

The proposed IFC investment is for an anchor subscription of up to $20 million in Georgian Lari (GEL) equivalent, in a local currency social bond (total value GEL $350 million) to be issued by Georgia Healthcare Group (GHG, the Company). 

GHG (https://ghg.com.ge/en/), the largest healthcare company in Georgia is 100% owned by Georgia Capital (GCap) which is listed on the London Stock Exchange. It operates a highly integrated business model with four key subsidiaries - Vian (large and specialty hospitals), Georgian Clinics (regional and community hospitals); Evex (polyclinics); and Megalab (diagnostics facilities. GCap is a current IFC client (GCap SL Bond #48231) and its Environmental and Social (E&S) performance in that investment has been satisfactory.

IFC’s funds will be directed at outpatient facilities and be used for:

(i)                  construction and equipping of a new oncology unit adjacent to and within the land plot of the existing Caucasus Medical Centre (CMC), Tbilisi’s leading referral hospital, and GHG megalab. The new unit will operate within the GHG Vian subsidiary. Key equipment to be provided through the bond comprises up to three cyclotron particle accelerators; one Computed Tomography (CT) simulator, one Magnetic Resonance Imaging (MRI) scanner and 17 chemotherapy beds, with provision made for future installation of Positron Emission Tomography (PET)-CT scanning units;

(ii)               procurement and installation of a linear accelerator (LINAC) and ultrasound scanners at Krystyna Kiel Oncology Center, part of the Vian subsidiary; 

(iii)             procurement and installation of ultrasounds scanners, and general modernization across the network of  polyclinics; and

(iv)              Purchase and installation of lab equipment, computer hardware and software at the diagnostics facilities.

The use of proceeds will be split approximately evenly between the construction and equipping of the new outpatient oncology unit and the provision of new equipment to existing outpatient polyclinics, the Krystyna Kiel Oncology Centre and diagnostics facilities

While GHG will have overall responsibility for equipment purchase and operational management of the assets, the construction management of the new oncology unit will be outsourced to a specialist healthcare construction management company.                             

 

Overview of IFC's Scope of Review

The E&S appraisal focused on evaluating CMC’s E&S and Health and Safety (H&S) management systems, which will be applied to construction and operation of the new oncology facility where the cyclotron accelerators will be provided, against the IFC Performance Standards and World Bank Group General Environmental, Health, and Safety (EHS) Guidelines and those for Health Care facilities. Documents reviewed included GHG and CMC E&S policies and procedures, including those prepared as part of its recent Joint Commission International (JCI) certification, as well as CMC specific E&S material provided in response to a questionnaire. Several on-line meetings were held in April and May 25, with management staff responsible for E&S and OHS performance and human resources (HR) at GHG, Vian and CMC levels and a virtual Life and Fire safety (LFS)appraisal was undertaken of two representative polyclinics in July 2025.

E & S Project Categorization and Applicable Standard

Environmental and Social Mitigation Measures

Stakeholder Engagement

Broad Community Support

Environmental & Social Action Plan